Company
Headquarters: Rehovot, Israel
Employees: 50
CEO: Mr. Kfir Gindi
₪62.1 Million
ILS as of Jan. 1, 2023
US$17.7 Million
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $461.52 B |
| Vertex Pharmaceuticals Incorporated | $107.23 B |
| Regeneron Pharmaceuticals, Inc. | $100.01 B |
| CSL Limited | $94.74 B |
| Marinomed Biotech AG | $73.23 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Cannomed Medical Cannabis Industries Ltd. engages in the cultivation, production, marketing, and sale of medical cannabis in Israel and internationally. The company operates through Pharmacies; and Growing, Producing, and Selling Medical Cannabis segments. It owns three pharmacies, which sell cosmetics, convenience and toiletries, medicines, and food supplements. The company was formerly known as Proteologics Ltd. and changed its name to Cannomed Medical Cannabis Industries Ltd. in February 2019. The company was incorporated in 1999 and is based in Tel Aviv-Yafo, Israel.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Cannomed Medical Cannabis Industries Ltd has the following listings and related stock indices.
Stock: TASE: CNMD wb_incandescent